B. LYNNE PARSHALL - 17 Jun 2025 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s/ Michael LaCascia, Attorney-in-Fact for B. Lynne Parshall
Issuer symbol
FHTX
Transactions as of
17 Jun 2025
Net transactions value
+$119,750
Form type
4
Filing time
17 Jun 2025, 16:29:16 UTC
Previous filing
15 May 2025
Next filing
02 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PARSHALL B LYNNE Director 500 TECHNOLOGY SQUARE, STE 700, CAMBRIDGE /s/ Michael LaCascia, Attorney-in-Fact for B. Lynne Parshall 17 Jun 2025 0001073385

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Award $119,750 +25,000 $4.79 25,000 17 Jun 2025 Common Stock 25,000 $4.79 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.